Phase II Trial of Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases.

Next Previous
Trial Profile

Phase II Trial of Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Carboplatin; Trastuzumab
  • Indications Breast cancer; Cancer metastases
  • Focus Therapeutic Use

    • Most Recent Events

    • 10 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 21 Jan 2014 Planned End Date changed from 1 Oct 2013 to 1 Feb 2016 as per ClinicalTrials.gov record.
    • 11 Sep 2012 Planned End Date changed from 1 Oct 2011 to 1 Oct 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top